Liminatus Pharma Return on Net Operating Assets Analysis

Liminatus Pharma, Inc. (LIMN)

0.2028 0.00 (0.00%) USD | NASDAQ | May 08, 16:00

0.201 0.00 (0.00%) After-Hours: 20:00

View Return on Net Operating Assets for LIMN.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Return on Net Operating Assets Chart

Start Trial

View Historical Data

Start Trial

View Return on Net Operating Assets Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Return on Net Operating Assets Benchmarks

Start Trial

Oruka Therapeutics, Inc.	Upgrade
MapLight Therapeutics, Inc.	Upgrade
Kailera Therapeutics, Inc.	--
Veracyte, Inc.	Upgrade
Insight Molecular Diagnostics, Inc.	Upgrade

Upgrade